TY  - JOUR
AU  - Gil, Robert J.
AU  - Bil, Jacek
AU  - Grundeken, Maik J.
AU  - Kern, Adam
AU  - Inigo Garcia, Luis A.
AU  - Vassilev, Dobrin
AU  - Pawlowski, Tomasz
AU  - Formuszewicz, Radoslaw
AU  - Dobrzycki, Slawomir
AU  - Wykrzykowska, Joanna J.
AU  - Serruys, Patrick W.
PY  - 2016
DO  - 10.4244/EIJY15M11_11
SN  - 1774-024X
UR  - https://hdl.handle.net/10668/26751
T2  - Eurointervention
AB  - Aims: The aim of the POLBOS II randomised trial was to compare any regular drug-eluting stents (rDES) with the dedicated bifurcation sirolimus-eluting stent BiOSS LIM for the treatment of coronary bifurcation lesions. The secondary aim was to study...
LA  - en
PB  - Europa edition
KW  - BiOSS LIM r
KW  - dedicated bifurcation stent
KW  - sirolimus-eluting stent
KW  - Strut thickness
KW  - Lesions
KW  - Restenosis
KW  - Classification
KW  - Consensus
KW  - Registry
KW  - Disease
KW  - Impact
TI  - Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM (R) stent: the randomised, multicentre, open-label, controlled POLBOS II trial
TY  - research article
VL  - 12
ER  -